Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹29.1863 | ₹91.6982 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.4 years | 10.0 years |
| Expense ratio | 0.2% | 0.1% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| 1 month | +10.82% | +4.04% |
| 3 months | +7.43% | −1.94% |
| 6 months | +14.54% | −12.42% |
| YTD | +25.40% | +0.08% |
| 1 year | +25.57% | −1.79% |
| 3 years (CAGR) | +22.02% | +17.10% |
| 5 years (CAGR) | +16.60% | +25.18% |
| 10 years (CAGR) | — | +13.94% |
| Since launch | +14.02% | +13.84% |
Risk
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Volatility | 15.0% | 21.3% |
| Downside volatility | 9.0% | 12.3% |
| Sharpe | 1.04 | 0.50 |
| Sortino | 1.72 | 0.86 |
| Calmar | 1.33 | 0.61 |
| Return / risk | 1.47 | 0.80 |
| Deepest fall | −20.98% | −54.09% |
| Days to recover | 136 | 565 |
| Below its high | −1.75% | −15.77% |
Against benchmark
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Alpha | +0.00% | — |
| Beta | 1.00 | — |
| R² | 100.0% | — |
| Up capture | 100.0% | — |
| Down capture | 100.0% | — |
| Tracking error | 0.0% | — |
| Information ratio | — | — |
| Treynor | 0.14 | — |
Consistency
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Best 1-year | +65.21% | +134.56% |
| Middle 1-year | +13.46% | +11.81% |
| Worst 1-year | −15.30% | −46.35% |
| 1-year periods with a loss | 25.8% | 36.2% |
| Middle 3-year | +20.51% | +24.32% |
| Positive months | 61.1% | 52.8% |
| Best day | +3.64% | +7.16% |
| Worst day | −4.03% | −15.04% |
| Worst 5% day | −1.62% | −1.88% |
| Positive days | 54.4% | 54.3% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| 5-year XIRR | +20.60% | +18.89% |
| 5-year value | ₹10,11,738 | ₹9,69,759 |
| 3-year XIRR | +19.58% | +2.81% |
| 1-year XIRR | +34.31% | −8.18% |
Holdings overlap i
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Nippon India Nifty Pharma ETF | — | 0% |
| CPSE ETF | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Sectors and company size
| Nippon India Nifty Pharma ETF | CPSE ETF | |
|---|---|---|
| Large companies | 45.3% | 86.9% |
| Mid companies | 47.1% | 11.4% |
| Small companies | 7.6% | 1.7% |
| Top 10 holdings | 78.6% | 99.4% |
| Largest sector | Pharmaceuticals & Biotechnology 100% | Power 45% |